HANOVER, Md., June 17, 2025 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) , today announced that it has entered into a binding term sheet with Intact Therapeutics, Inc ...

Homerun Resources Inc. Executes Binding Term Sheet with Institutional Investor for $6 Million Financing Newsfile - Newsfile - Mon Jun 16, 7:22PM CDT ...

Homerun Resources Inc. is pleased to announce that it has executed a binding term sheet with an arm's length institutional investor in connection with a proposed financing for $6,000,000.00 ...

Vancouver, British Columbia--(Newsfile Corp. - June 16, 2025) - <b> Homerun Resources Inc. (TSXV: HMR) (OTCQB: HMRFF) (Homerun or the Company) < ...

Galantas Gold Enters Into Binding Term Sheet for Joint Venture With Ocean Partners UK Limited to Develop Omagh Gold Project in Northern Ireland Galantas Gold Corporation - GlobeNewswire - Mon Jun ...

Ocugen Inc, a biotechnology company focused on discovering, developing, and commercializing novel gene therapies to address major blindness diseases and offer hope for patients across the globe, ...

MALVERN, Pa., June 05, 2025 (GLOBE NEWSWIRE) -- Ocugen, Inc., a pioneering biotechnology leader in gene therapies for blindness diseases, today announced the signing of a binding term sheet to ...

Ocugen, Inc. has signed a binding term sheet to negotiate a licensing agreement for OCU400, its gene therapy for retinitis pigmentosa (RP), with a major pharmaceutical company in Korea, granting ...